Latest Content

Herb and Supplement Use During Cancer Treatment May Cause Drug Interactions That Could Be Harmful for Patients

March 2nd 2021, 7:00pm

By Colleen Moretti


Patients with prostate and breast cancer may be unknowingly putting themselves at risk while taking herbs and supplements during chemotherapy and should consult their medical team before using them, according to an expert.

Slowing Down is OK

March 2nd 2021, 5:00pm

By Jane Biehl Ph.D.


A cancer survivor laments the fact that she no longer moves as fast as she once did when she was younger. However, she has come to the realization that moving slow is OK as it allows her to enjoy life.

Johnson & Johnson’s Single-Dose COVID-19 Vaccine a ‘Tremendous Asset’ for Patients With Cancer

March 2nd 2021, 4:00pm

By Ryan McDonald


An expert from the Roswell Park Comprehensive Cancer Center recommends that patients with cancer get whichever vaccine is available at the time they go to get vaccinated.

A Non-Small Cell Lung Cancer Survivor Shares Her Story

March 2nd 2021, 2:00pm

By Darlene Dobkowski, MA


A young mother and athlete discusses receiving a shocking diagnosis of stage 4 lung cancer and her incredible response to treatment with a single, targeted drug.

What’s Next After Hedgehog Therapy Fails for Basal Cell Carcinoma?

March 1st 2021, 10:00pm

By Darlene Dobkowski, MA


A patient with recurrent basal cell carcinoma discusses his cancer journey, his latest challenge and how he’s now prioritized quality of life over quantity.

Here’s What Cancer Survivors and Patients Don’t Want to Hear From Family and Friends

March 1st 2021, 7:00pm

By Ryan McDonald


On social media, CURE® recently asked its readers to share what they want to hear from family and friends and what they don’t want to hear.

When It Comes to Cancer, See the Person and Not the Disease

March 1st 2021, 5:00pm

By Eileen Weinmann


An oncology nurse offers people tips on how to find the courage and be better advocates to their loved ones who may be receiving treatment for cancer.

Educating Others With Clinical Knowledge and Personal Experience

March 1st 2021, 4:00pm

By Darlene Dobkowski, MA


Although a gynecologic oncologist has spent a good part of her career helping patients during their cancer journeys, she took it upon herself to take one step further to educate women on how they can advocate for themselves and potentially prevent cancer before it impacts their lives.

CURE’s Top Stories: February 2021

March 1st 2021, 2:00pm

By Jessica Skarzynski


Each month, we take a look back at the most popular CURE® stories. Here are the top five stories for February 2021.

The COVID-19 Pandemic Has Reminded Us All About the Importance of a Phone Call

February 28th 2021, 4:00pm

By Ron Cooper


Call volumes increased to jaw-dropping numbers during the beginning of the pandemic, and this cancer survivor hopes that trend continues even after we are out of the pandemic.

Team Efforts Propel Cancer Victories

February 28th 2021, 12:30am

By Mike Hennessy, Sr.


It’s always best to have a team of people, whether friends or family, rooting us on as we face whatever challenges come our way.

FDA Authorizes Johnson & Johnson’s Single-Dose COVID-19 Vaccine, Marking Third Vaccine in US

February 28th 2021, 12:00am

By Ryan McDonald


The Johnson & Johnson vaccine is delivered in a single dose, which is a departure from the two doses required for the already available Pfizer-BioNTech and Moderna vaccines.

How Life Lessons from My Parents, a Former Employer and a Holocaust Survivor Have Helped Me During My Cancer Journey

February 27th 2021, 7:00pm

By Marissa Holzer


A patient with metastatic breast cancer recalls how she’s been told countless times that she’s so brave, so strong and so resilient. Here, she thanks those who have influenced her and helped her be so courageous.

Treatment Advances Transform CML Into Chronic Disease

February 27th 2021, 4:00pm

By Debu Tripathy, M.D.


Over the past decade, advances in both diagnostics and therapeutics in a variety of blood cancers have turned certain diseases into chronic conditions.

FDA Approves Pepaxto Combination for Relapsed/Refractory Multiple Myeloma

February 27th 2021, 12:30am

By Kristie L. Kahl


The agency granted accelerated approval to Pepaxto in combination with dexamethasone in adult patients with relapsed or refractory multiple myeloma, who received at least four prior lines of therapy.